Garnier, Camille <br/><br/>
Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.  [electronic resource] 

 -  The Journal of rheumatology  11 2018 
 - 1541-1548 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1499-2752 
<br/><br/><label>Standard No.: </label>10.3899/jrheum.180310  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--therapeutic use<br/>Cyclophosphamide--adverse effects<br/>Female<br/>Herpes Zoster--epidemiology<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Incidence<br/>Lupus Erythematosus, Systemic--complications<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Risk Factors<br/>Vasculitis--complications<br/>Young Adult